Yahoo Finance - YXJM Finance Hub

Yahoo Finance

Palantir upgraded, Best Buy downgraded: Wall Street's top analyst calls

Palantir upgraded, Best Buy downgraded: Wall Stree...

2 months ago 22

C3.ai (AI) Stays Central to AI Debate as Capital Intensity Challenges Investor Confidence

C3.ai (AI) Stays Central to AI Debate as Capital I...

2 months ago 22

'It's All On Paper' – Gymshark Founder, Worth $1.4B, Says You Should Never Link Self-Worth With Money, Thinks It's 'Wildly Unproductive' Way To Live

'It's All On Paper' – Gymshark Founder, Worth $1.4...

2 months ago 20

1 Under-the-Radar AI Stock With Explosive Growth Potential

1 Under-the-Radar AI Stock With Explosive Growth P...

2 months ago 25

H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)’s Carvykti Despite Sales Miss

H.C. Wainwright Highlight Curative Potential of Le...

2 months ago 19

Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results

Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahe...

2 months ago 21

Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX)

Analysts Bullish Ahead of Colorectal Cancer Readou...

2 months ago 18

Baird Updates Intellia Therapeutics, Inc. (NTLA)’s Financial Model Following Nex-Z Clinical Hold Removal

Baird Updates Intellia Therapeutics, Inc. (NTLA)’s...

2 months ago 20

Taysha Gene Therapies, Inc. (TSHA) Gains Wells Fargo’s Support on Rett Syndrome Program Progress

Taysha Gene Therapies, Inc. (TSHA) Gains Wells Far...

2 months ago 20

Janux Therapeutics, Inc. (JANX) Faces Platform Risk Amid Lack of Durability Data on JANX007

Janux Therapeutics, Inc. (JANX) Faces Platform Ris...

2 months ago 15

Goldman Sachs Notes VELA-2 Failure, Calls MoonLake Immunotherapeutics (MLTX) a High-Risk Play

Goldman Sachs Notes VELA-2 Failure, Calls MoonLake...

2 months ago 15

uniQure (QURE) Navigates Gene Therapy Development as Investors Weigh Long-Term Potential

uniQure (QURE) Navigates Gene Therapy Development ...

2 months ago 15

Fed Chair Nominee Kevin Warsh Has Called Bitcoin The 'New Gold', Yet BTC Is Down 3%

Fed Chair Nominee Kevin Warsh Has Called Bitcoin T...

2 months ago 15

Stifel Raised Nurix Therapeutics, Inc. (NRIX) Price Target to $35 and Maintains Buy Ahead of 2026 Catalysts

Stifel Raised Nurix Therapeutics, Inc. (NRIX) Pric...

2 months ago 14

Jefferies Downgrades Amicus Therapeutics, Inc. (FOLD) to Buy And Lowers Price Target Amid Takeover Developments

Jefferies Downgrades Amicus Therapeutics, Inc. (FO...

2 months ago 15

Rosenblatt Highlights Tax Incentives and Sales Execution as Q4 Upside Drivers for Fortinet, Inc. (FTNT)

Rosenblatt Highlights Tax Incentives and Sales Exe...

2 months ago 16

Amphenol Corporation (APH) Gains Attention After Dual Price Target Raises

Amphenol Corporation (APH) Gains Attention After D...

2 months ago 15

William Blair Notes Rambus Inc. (RMBS) Positioned as Top DRAM Memory Supplier

William Blair Notes Rambus Inc. (RMBS) Positioned ...

2 months ago 15